# FDA Warning Letter: BioMylz Pvt. Ltd.
> 2026-07-21 · Center for Drug Evaluation and Research (CDER) · `7cc85f7dae4e3f33`
## Letter
- **Company:** BioMylz Pvt. Ltd.
- **Posted Date:** 2026-07-21
- **Letter Issue Date:** 2026-07-13
- **Issuing Office:** Center for Drug Evaluation and Research (CDER)
## Subject
CGMP/Finished Pharmaceuticals/Adulterated/Misbranded
---
*Source: [FDA Warning Letters](https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters) · MORVS · CC0 1.0*